Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

miR-22 in tumorigenesis.

Song SJ, Pandolfi PP.

Cell Cycle. 2014;13(1):11-2. doi: 10.4161/cc.27027. Epub 2013 Nov 14. No abstract available.

2.

Oncogenic miRNAs and the perils of losing control of a stem cell's epigenetic identity.

Dalerba P, Clarke MF.

Cell Stem Cell. 2013 Jul 3;13(1):5-6. doi: 10.1016/j.stem.2013.06.012.

3.

MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling.

Song SJ, Poliseno L, Song MS, Ala U, Webster K, Ng C, Beringer G, Brikbak NJ, Yuan X, Cantley LC, Richardson AL, Pandolfi PP.

Cell. 2013 Jul 18;154(2):311-324. doi: 10.1016/j.cell.2013.06.026. Epub 2013 Jul 3.

4.

Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state.

Lim YY, Wright JA, Attema JL, Gregory PA, Bert AG, Smith E, Thomas D, Lopez AF, Drew PA, Khew-Goodall Y, Goodall GJ.

J Cell Sci. 2013 May 15;126(Pt 10):2256-66. doi: 10.1242/jcs.122275. Epub 2013 Mar 22.

5.

MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells.

Han M, Wang Y, Liu M, Bi X, Bao J, Zeng N, Zhu Z, Mo Z, Wu C, Chen X.

Cancer Sci. 2012 Jun;103(6):1058-64. doi: 10.1111/j.1349-7006.2012.02281.x. Epub 2012 Apr 23.

6.

MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.

Gwak JM, Kim HJ, Kim EJ, Chung YR, Yun S, Seo AN, Lee HJ, Park SY.

Breast Cancer Res Treat. 2014 Aug;147(1):39-49. doi: 10.1007/s10549-014-3069-5. Epub 2014 Aug 3.

PMID:
25086633
7.

Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs.

Guttilla IK, Phoenix KN, Hong X, Tirnauer JS, Claffey KP, White BA.

Breast Cancer Res Treat. 2012 Feb;132(1):75-85. doi: 10.1007/s10549-011-1534-y. Epub 2011 May 7.

PMID:
21553120
8.

MicroRNA-200c overexpression plays an inhibitory role in human pancreatic cancer stem cells by regulating epithelial-mesenchymal transition.

Ma C, Ding YC, Yu W, Wang Q, Meng B, Huang T.

Minerva Med. 2015 Aug;106(4):193-202. Epub 2015 Jun 17.

PMID:
26081037
9.

Autocrine/Paracrine Human Growth Hormone-stimulated MicroRNA 96-182-183 Cluster Promotes Epithelial-Mesenchymal Transition and Invasion in Breast Cancer.

Zhang W, Qian P, Zhang X, Zhang M, Wang H, Wu M, Kong X, Tan S, Ding K, Perry JK, Wu Z, Cao Y, Lobie PE, Zhu T.

J Biol Chem. 2015 May 29;290(22):13812-29. doi: 10.1074/jbc.M115.653261. Epub 2015 Apr 14.

10.

Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.

Ren D, Wang M, Guo W, Huang S, Wang Z, Zhao X, Du H, Song L, Peng X.

Cell Tissue Res. 2014 Dec;358(3):763-78. doi: 10.1007/s00441-014-2001-y. Epub 2014 Oct 9.

PMID:
25296715
11.

[Epithelial-mesenchymal transition and cancer stem cells].

Zou DD, Tang XB.

Zhonghua Bing Li Xue Za Zhi. 2013 Jan;42(1):62-5. doi: 10.3760/cma.j.issn.0529-5807.2013.01.018. Review. Chinese. No abstract available.

PMID:
23611281
12.

MicroRNA 34c gene down-regulation via DNA methylation promotes self-renewal and epithelial-mesenchymal transition in breast tumor-initiating cells.

Yu F, Jiao Y, Zhu Y, Wang Y, Zhu J, Cui X, Liu Y, He Y, Park EY, Zhang H, Lv X, Ma K, Su F, Park JH, Song E.

J Biol Chem. 2012 Jan 2;287(1):465-73. doi: 10.1074/jbc.M111.280768. Epub 2011 Nov 10.

13.

Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma.

Yan H, Dong X, Zhong X, Ye J, Zhou Y, Yang X, Shen J, Zhang J.

Mol Carcinog. 2014 Dec;53(12):960-9. doi: 10.1002/mc.22064. Epub 2013 Jul 17.

PMID:
23861222
14.

MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression.

Kong X, Li G, Yuan Y, He Y, Wu X, Zhang W, Wu Z, Chen T, Wu W, Lobie PE, Zhu T.

PLoS One. 2012;7(8):e41523. doi: 10.1371/journal.pone.0041523. Epub 2012 Aug 2.

15.

Recurrence and metastasis of breast cancer is influenced by ovarian hormone's effect on breast cancer stem cells.

Nandy SB, Gangwani L, Nahleh Z, Subramani R, Arumugam A, de la Rosa JM, Lakshmanaswamy R.

Future Oncol. 2015;11(6):983-95. doi: 10.2217/fon.14.301. Review.

PMID:
25760978
16.

MiR-7, inhibited indirectly by lincRNA HOTAIR, directly inhibits SETDB1 and reverses the EMT of breast cancer stem cells by downregulating the STAT3 pathway.

Zhang H, Cai K, Wang J, Wang X, Cheng K, Shi F, Jiang L, Zhang Y, Dou J.

Stem Cells. 2014 Nov;32(11):2858-68. doi: 10.1002/stem.1795.

17.

MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.

Xia H, Hui KM.

Cancer Gene Ther. 2012 Nov;19(11):723-30. doi: 10.1038/cgt.2012.58. Epub 2012 Sep 14. Review.

PMID:
22975591
18.

MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.

Zhou JN, Zeng Q, Wang HY, Zhang B, Li ST, Nan X, Cao N, Fu CJ, Yan XL, Jia YL, Wang JX, Zhao AH, Li ZW, Li YH, Xie XY, Zhang XM, Dong Y, Xu YC, He LJ, Yue W, Pei XT.

Hepatology. 2015 Sep;62(3):801-15. doi: 10.1002/hep.27887. Epub 2015 Jul 3.

PMID:
25953743
19.

The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis.

Huang TT, Ping YH, Wang AM, Ke CC, Fang WL, Huang KH, Lee HC, Chi CW, Yeh TS.

Oncotarget. 2015 Jul 20;6(20):18012-26.

20.

Review of miR-200b and cancer chemosensitivity.

Feng B, Wang R, Chen LB.

Biomed Pharmacother. 2012 Sep;66(6):397-402. doi: 10.1016/j.biopha.2012.06.002. Epub 2012 Jun 29. Review.

PMID:
22795796

Supplemental Content

Support Center